ElizabethEllaPuscheckMD

Reproductive Endocrinology & Infertility

Professor, Obstetrics & Gynecology, Wayne State University School of Medicine

Dr. Puscheck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
InVia Fertility
1585 Barrington Road, Ste 406
Hoffman Estates, IL 60169
Phone+1 847-884-8884

Fax+1 847-884-0924

University of TennesseeM.B.A., 2016 - 2016
Medical College of GeorgiaFellowship, Reproductive Endocrinology and Infertility, 1991 - 1993
Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 1987 - 1991
Washington University in St. Louis School of MedicineClass of 1987
University of ChicagoM.S., Arts and Sciences Basic to Human Biology, 1983 - 1985
University of ChicagoA.B., Biology and Anthropology, Honors, 1979 - 1983

IL State Medical License 1993 - 2026
CA State Medical License 1994 - 2025
MI State Medical License 2000 - 2025
GA State Medical License 1991 - 1993
PA State Medical License 1990 - 1992
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

PubMed

Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020

Research Finds Stress Reduces Viral Resistance Against COVID-19 in Embryonic Stem CellsAugust 10th, 2021
AIUM Practice Parameter for the Performance of a Focused Ultrasound Examination in Reproductive Endocrinology and Female InfertilityFebruary 13th, 2019

A phase 3 study to evaluate the safety and efficacy of Elagolix in combination with Estradiol/Northindrone Acetate in Subjects with Moderate Endometriosis.AbbVie2016–2023
A Randomized, double-blind, double-dummy, trial comparing MENOPUR solution for injection in a pre-filled pen and MENOPUR Powder and solvent for solution for injection (Menotropins for injection) in aFerring Pharmaceuticals2019–2021
A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 34-42 years undergoFerring Pharmaceuticals2018–2021
A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 18-34 years undergoFerring Pharmaceuticals2018–2021
Extension study to evaluate the efficacy and safety of Elagolix in premenopausal women with heavy menstrual bleeding associated with uterine fibroids.Abbvie2017–2020
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study, investigating the efficacy and safety of daily oral administration of InvDrug alone and in combination with add-back therapyObseva2017–2020
WSU Cooperative Reproductive Medicine Network CenterNICHD2007–2019
Detroit Reproductive Career Development Research Center (WRHR)NIH/NICHD2011–2016